{"transactions":[{"id":4118324,"issuer":{"id":69367,"kind":"organization","name":"ACURA PHARMACEUTICALS, INC","symbol":"ACUR"},"owners":[{"id":170776,"kind":"organization","name":"CLAUDIUS LLC","position":1,"cik":"0001056643","reported_name":"CLAUDIUS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":170777,"kind":"organization","name":"GALEN PARTNERS INTERNATIONAL III L P","position":2,"cik":"0001034574","reported_name":"GALEN PARTNERS INTERNATIONAL III L P","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":170778,"kind":"organization","name":"GALEN EMPLOYEE FUND III LP","position":3,"cik":"0001056642","reported_name":"GALEN EMPLOYEE FUND III LP","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":164770,"kind":"organization","name":"Galen Management, LLC","position":4,"cik":"0001421162","reported_name":"Galen Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}},{"id":170779,"kind":"organization","name":"GALEN PARTNERS III L P","position":5,"cik":"0001034486","reported_name":"GALEN PARTNERS III L P","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% owner"}}],"security":"Common Stock","published_at":"2018-01-02T23:11:59.000Z","date":"2017-12-14","kind":"sale","acquired":false,"shares":2195734,"price":0.1,"value":219573.4,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold in a private transaction pursuant to a stock purchase agreement by and among Galen Partners III, LP (\"Galen III\"), Galen Employee Fund III, LP, (\"Employee Fund\") Galen Partners International III, LP (\"Galen International\") and several purchasers."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares were sold as follows:  2,006,540 by Galen III, 180,928 by Galen International and 8,266 by Employee Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Claudius, L.L.C. serves as the sole General Partner of Galen III and Galen International and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds.  Galen Management, L.L.C. serves as the sole General Partner of Employee Fund and has sole voting and investment control over the shares held by Employee Fund and may be deemed to beneficially own the shares held by Employee Fund.  Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-000346","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/786947/000120919118000346/doc4.xml","form_type":"4"}}]}